Y si comparamos con JNJ a 125$ pues…
| Empresa | Johnson and Johnson | Roche |
|---|---|---|
| Year | 2019 | 2019 |
| Share price | $125,00 | 310,00 CHF |
| Number of shares | 2.632.507.000 | 864.000.000 |
| Capitalización | 329.063 | 267.840 |
| Net debt (cash) | 18.978 | 10.930 |
| EV | $348.041 | 278.770 CHF |
| PER | 21,76 | 19,84 |
| RPD | 3,00% | 2,81% |
| Payout | 65,29% | 55,69% |
| EV/EBITDA | 12,98 | 12,76 |
| EV/EBIT | 17,57 | 15,89 |
| EV/CFO | 14,86 | 12,45 |
| EV/FCF | 17,14 | 17,51 |
| Net debt/EBITDA | 0,71 | 0,50 |
| Net debt/EBIT | 0,96 | 0,62 |
| Deuda/Capital | 31,77% | 28,59% |
| P/S | 4,01 | 4,20 |
| P/B | 5,53 | 7,47 |